Literature DB >> 27000642

Headache and Its Approach in Today's NeuroIntensive Care Unit.

Laxmi P Dhakal1, Andrea M Harriott2, David J Capobianco2, William D Freeman3.   

Abstract

Headache is a very common symptom in the neurointensive care unit (neuroICU). While headache in the neuroICU can be caused by worsening of a pre-existing primary headache disorder, most are secondary to another condition. Additionally, headache can be the presenting symptom of a number of conditions requiring prompt recognition and treatment including subarachnoid hemorrhage, ischemic and hemorrhagic stroke, central nervous system infection, pituitary apoplexy, and cerebral vasoconstriction. The neuroICU also has a unique postoperative population in which postcraniectomy and postcraniotomy headache, postintravascular intervention headache, hyperperfusion syndrome, ventriculitis, medication overuse or withdrawal headache, and hypercapnia may be encountered. Management varies dramatically depending on the etiology of the headache. Overreliance on opiate analgesics may produce significant adverse effects and lengthen ICU stays. However, nonnarcotic medications are increasingly being recognized as helpful in reducing the pain among various postsurgical and headache patients. Taken together, a multimodal approach targeting the underlying pathology and choosing appropriate systemic and local analgesic medications may be the best way to manage headache in critically ill patients.

Entities:  

Keywords:  Headache; Headache management; Intensive care unit; Multimodal approach; Neurocritical care

Mesh:

Year:  2016        PMID: 27000642     DOI: 10.1007/s12028-016-0260-z

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  93 in total

Review 1.  Diagnosing acute headache.

Authors:  Richard Davenport
Journal:  Clin Med (Lond)       Date:  2004 Mar-Apr       Impact factor: 2.659

Review 2.  Posterior reversible encephalopathy syndrome in intensive care medicine.

Authors:  Giuseppe Servillo; Francesca Bifulco; Edoardo De Robertis; Ornella Piazza; Pasquale Striano; Fabio Tortora; Salvatore Striano; Rosalba Tufano
Journal:  Intensive Care Med       Date:  2006-11-21       Impact factor: 17.440

3.  Brain AVM embolization with Onyx.

Authors:  W J van Rooij; M Sluzewski; G N Beute
Journal:  AJNR Am J Neuroradiol       Date:  2007-01       Impact factor: 3.825

4.  Pearls: headache.

Authors:  David W Dodick
Journal:  Semin Neurol       Date:  2010-02-01       Impact factor: 3.420

Review 5.  Thunderclap headache: diagnostic considerations and neuroimaging features.

Authors:  A M Mortimer; M D Bradley; N G Stoodley; S A Renowden
Journal:  Clin Radiol       Date:  2012-12-11       Impact factor: 2.350

Review 6.  Imaging lesions of the cavernous sinus.

Authors:  A A K Abdel Razek; M Castillo
Journal:  AJNR Am J Neuroradiol       Date:  2008-12-18       Impact factor: 3.825

Review 7.  Calcium antagonists for aneurysmal subarachnoid haemorrhage.

Authors:  G J Rinkel; V L Feigin; A Algra; M Vermeulen; J van Gijn
Journal:  Cochrane Database Syst Rev       Date:  2002

Review 8.  Invasive fungal sinusitis and complications of rhinosinusitis.

Authors:  Victoria A Epstein; Robert C Kern
Journal:  Otolaryngol Clin North Am       Date:  2008-06       Impact factor: 3.346

9.  Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage.

Authors:  G S Allen; H S Ahn; T J Preziosi; R Battye; S C Boone; S C Boone; S N Chou; D L Kelly; B K Weir; R A Crabbe; P J Lavik; S B Rosenbloom; F C Dorsey; C R Ingram; D E Mellits; L A Bertsch; D P Boisvert; M B Hundley; R K Johnson; J A Strom; C R Transou
Journal:  N Engl J Med       Date:  1983-03-17       Impact factor: 91.245

10.  Persistent primary thunderclap headache responsive to gabapentin.

Authors:  Ivan Garza; David F Black
Journal:  J Headache Pain       Date:  2006-12-10       Impact factor: 7.277

View more
  1 in total

1.  Migraine Headaches after Major Surgery with General or Neuraxial Anesthesia: A Nationwide Propensity-Score Matched Study.

Authors:  Chung-Yi Liao; Chun-Cheng Li; Hsin-Yi Liu; Jui-Tai Chen; Yih-Giun Cherng; Tzeng-Ji Chen; Ying-Xiu Dai; Hsiang-Ling Wu; Wan-Chi Liu; Ying-Hsuan Tai
Journal:  Int J Environ Res Public Health       Date:  2021-12-30       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.